David R. Rahn & Associates Inc. Zoetis Inc. Transaction History
David R. Rahn & Associates Inc.
- $323 Million
- Q3 2024
A detailed history of David R. Rahn & Associates Inc. transactions in Zoetis Inc. stock. As of the latest transaction made, David R. Rahn & Associates Inc. holds 1,759 shares of ZTS stock, worth $288,968. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,759Holding current value
$288,968% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding ZTS
# of Institutions
1,957Shares Held
410MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$6.78 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.05 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.25 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.63 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.53 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $76.9B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...